In the long battle against cancer, human beings have moved from chemotherapy and radiation to targeted drugs, and now to cell-based therapies.Among these innovations, CAR-T cell ...
September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...